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Table 1
Combined MTHFR C677T/A1298C Genotype or Allele Frequencies
in a Hispanic Population of Mexican Descent, Composed of















CT/CC .003 .000 .007 .012
TT/AC .020 .028 .021 .024
TT/CC .000 .004 .000 .000
MTHFR allele:
677C .493 .477 .549 .527
677T .507 .523 .451 .473
1298A .854 .856 .815 .811
1298C .146 .144 .185 .189
ymptotic assumptions to calculate it. In any case, it would
seem preferable for analysts to quote one-sided P values
rather than to have to resort to the average bias-con-
trolling procedure suggested by Province—although this
should not be taken to imply that either P values or LOD
scores are completely satisfactory summary statistics.
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Examinations of Methylenetetrahydrofolate Reductase
C677T and A1298C Mutations—and In Utero
Viability
To the Editor:
The recently published study by Isotalo et al. (2000) an-
alyzed the methylenetetrahydrofolate reductase (MTHFR)
C677T and A1298C mutations in neonatal and fetal
groups, to determine whether particular MTHFR ge-
notype combinations are associated with decreased in
utero viability. Isotalo et al. (2000) observed all possible
genotype combinations in the fetal group, but combined
677CT/1298CC and 677TT/1298CC genotypes were
not observed in the neonatal group. Therefore, they hy-
pothesized that decreased viability exists among fetuses
carrying the 677CT/1298CC and 677TT/1298CC geno-
types, with a possible selection disadvantage in fetuses
with an increased number of mutant MTHFR alleles.
They also did not observe the 677CT/1298CC and
677TT/1298CC genotypes in a population consisting of
healthy adult controls.
We have tested for the MTHFR C677T and A1298C
mutations in a Hispanic population of Mexican descent,
to determine risk for spina bifida (SB) (Volcik et al. 2000).
Although we observed all possible MTHFR 677/1298 ge-
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Table 2
Combined MTHFR C677T/A1298C Genotype or Allele Frequencies
in a U.S. Population of European Descent, Composed of Patients















CT/CC .000 .020 .019 .015
TT/AC .038 .007 .019 .000
TT/CC .000 .000 .000 .000
MTHFR allele:
677C .578 .601 .551 .682
677T .422 .409 .449 .318
1298A .694 .721 .734 .712
1298C .306 .279 .266 .288
Table 3
Combined MTHFR C677T/A1298C Genotype or Allele Frequencies
in a Canadian Population of European Descent, Composed of













CT/CC .022 .067 .033
TT/AC .022 .000 .000
TT/CC .000 .000 .000
MTHFR allele:
677C .641 .722 .683
677T .359 .278 .317
1298A .696 .589 .667
1298C .304 .411 .333
notype combinations in this Hispanic population, the
677TT/1298CC combination was observed only once, in
the mother of an affected individual (table 1). We have
analyzed the MTHFR C677T and A1298C mutations in
a U.S. population of European descent, composed of pa-
tients with SB, their parents, and controls, and have ob-
served the 677CT/1298CC genotype combination (table
2). In addition, we have observed the MTHFR C677T
and A1298C mutations in a Canadian population of Eu-
ropean descent, composed of patients with SB and their
parents (table 3). We observed only a single individual, a
patient with SB, with the 677TT/1298AC genotype.
However, because of the small size of our sample, we
expected that only one or two individuals in each of the
groups would have the 677TT/1298AC genotype. It is
therefore difficult to reach conclusions, on the basis of
the absence of this genotype in the small Canadian pop-
ulation that we studied. The presence of these geno-
types in healthy parents and controls militates against
the hypothesis, proposed by Isotalo et al. (2000), that
the absence of the 677CT/1298CC genotype suggests
that “additionalMTHFRmutations in cis are potentially
deleterious or lethal” (Isotalo et al. 2000, p. 989). Per-
haps it is the combination of two mutant alleles at both
sites (677TT/1298CC), reaching a threshold of four,
rather than three, mutations that creates a disadvantage.
Other groups have also identified individuals with the
677T and 1298C alleles in the cis configuration and
individuals with the mutations in the trans configuration
(Weisberg et al. 1998; Friedman et al. 1999).
An additional concern is that Isotalo et al. (2000) fail
to indicate the ethnicity of the population that they stud-
ied. Therefore, we have provided data from three ethnic
groups (Hispanics of Mexican descent, U.S. individuals
of European descent, and Canadians of European de-
scent), to compare genotype and allele frequencies. If the
population studied by Isotalo et al. (2000) was Canadi-
an, it is notable that they did not observe the 677CT/
1298CC genotype in their neonatal group, whereas we
observed this genotype in 2%–6% of the Canadian pop-
ulation, of patients with SB and their parents, that we
studied. Our data support the conclusion of Isotalo et al.
(2000) concerning decreased viability among fetuses with
the 677TT/1298CC genotype, because we did not observe
this genotype in the U.S. and Canadian populations that
we studied. Because we observed, in three different pop-
ulations, the 677CT/1298CC genotype at frequencies
nearing those expected, we conclude that this genotype
does not result in a significant selective disadvantage.
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Reply to Volcik et al.
To the Editor:
Volcik et al. (2001 [in this issue]) provide support-
ing evidence that methylenetetrahydrofolate reductase
(MTHFR) 677 and 1298 alleles have crossed over, as
we have demonstrated in fetal tissue and in antenatal
subjects (Isotalo et al. 2000). Their observations also
support the findings of Hanson et al. (2001), who dem-
onstrated, in a study of adults, a genotype frequency of
0.2% for both MTHFR 677CT/1298CC and MTHFR
677TT/1298AC. The only MTHFR crossover combi-
nation that we observed in an antenatal control group
was 677TT/1298AC (Isotalo et. al 2000). We hypoth-
esized that the allelic combinations 677TT/1298CC and
677CT/1298CC are potentially deleterious or lethal in
utero; however, the existence of 677CT/1298CC in both
adults and children with spina bifida (SB) casts some
doubt on our hypothesis.
A major consideration not addressed by Volcik et al.
(2001 [in this issue]), concerning their study group, is that
their study focused on children with SB and on their par-
ents. Children with SB have survived a fetal defect—one
that is known to cause stillbirth and miscarriage.Without
medical intervention, postgestational mortality in infants
with SB is high. Therefore, the MTHFR genotype com-
binations and frequencies observed in the nonviable group
that we studied may overlap with those in groups with SB.
Additionally, development of SB, as well as of other
neural-tube defects, can be reduced by folate sufficiency
and therefore is affected by diet and, possibly, by other
defects within the folate-delivery andmetabolic pathways.
Folate status has been shown to affect the contribution
of the MTHFR 677 genotype to SB (Christensen et al.
1999). Nutritional-status differences between the study
groups may influence the survival of specific genotypes.
The contribution that the mother makes to SB or to fetal
demise may be, in part, genetic—as was possibly the case
in the U.S. 677TT/1298AC representation—and most
certainly is in part due to maternal folate sufficiency. The
distribution of 677TT/1298AC combined genotypes was
well represented in all children with SB and in Hispanic
parents but not in U.S. parents. Notably, the only groups
with a strong representation of 677CT/1298CC, relative
to the 677TT/1298AC genotype, were the U.S. and Ca-
nadian mothers of children with SB. This is in contrast
to the lack of 677CT/1298CC in our Canadian antenatal
control group. Of 148 control subjects, Volcik et al. found
2 individuals with the 677CT/1298CC genotype.
Volcik et al.’s Canadian study group consisted of af-
fected families with SB and did not contain controls;
therefore, we find it difficult, in relation to our control
group, to draw conclusions concerning their findings of
the 677CT/1298CC combinations. Our Canadian group
was predominantly of European (Celtic) descent, al-
though some Canadians of other derivations were in-
cluded. It is interesting to note thatWeisberg et al. (1998)
also studied a Canadian population of children with SB
and their mothers and did not identify any individuals
with the 677CT/1298CC or 677TT/1298CC genotypes.
We still hypothesize that combined common poly-
morphisms of MTHFR play a role in fetal demise and
in the development of neural-tube defects. Maternal
MTHFR is in the position to affect the quantity and
form of folate delivered to the fetus, whereas fetal
MTHFR may subsequently affect the utilization and dis-
tribution of the supplied folate. The most important de-
terminant for the development of neural-tube defects,
however, is likely the initial folate sufficiency of the
mother. It is unfortunate that Volcik et al. did not ex-
amine patterns between the parental—in particular, the
maternal—MTHFR genotypes and the genotypes of the
children with SB that they studied. Perhaps there are
specific maternal/fetal combinations of MTHFR that
have a relationship with either fetal demise or the de-
velopment of SB.
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